The health benefit from fermented rice with Aspergillus sp. in working-age group Thai population: a randomized parallel trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210714008

Enrollment

Registered

2021-07-14

Start date

2021-09-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy human volunteers Gut microbiome

Interventions

Oligo-fructose 7 g/dose, 50 ml cocktails of near water/dose, 1 dose/day, oral administration in the morning,50 ml cocktails of near water without FOS/dose, 1 dose/day, oral administration in the morni

Experimental Dietary Supplement,Placebo Comparator Dietary Supplement

FOS,No_FOS

Eligibility

Sex/Gender

All

Age

20 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1 Thai citizen 2 During normal working hours

Exclusion criteria

Exclusion criteria: 1 Pregnant woman 2 Congenital diseases including Irritable Bowel Syndrome or Irritable Bowel disease, Liver disease and Kidney failure. 3 On drug of Antibiotic 4 On drug Immunosuppressive agents group or Chemotherapy or in case of Organ transplantation.

Design outcomes

Primary

Measure	Time frame
Concentration effect of microbial population at 6 months after end of the intervention qPCR	—

Secondary

Measure	Time frame
Difference of concentration effect amount microbial population at 6 months after end of the intervention NGS	—

Countries

Thailand

Contacts

Public ContactNiwed Kulawong

School of Health Science, Mea Fah Luang University

niwed.kul@mfu.ac.th0644565896

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026